Siguo Hao

机构：XinHua Hospital · ORCID：0000-0001-6381-7729

发表论文 107 篇 · 总被引 2355 次 · h-index 28

代表论文

• Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study (2024 · Clinical Cancer Research · 被引 15)
• Optimal timing and impact of allogeneic peripheral blood stem cell transplantation in adult T-cell lymphoblastic lymphoma: insights from a large cohort multi-center real-world study in Shanghai (2024 · Bone Marrow Transplantation · 被引 4)
• Safety and efficacy of a pre-phase with dexamethasone followed by fractionated R-CHOP in diffuse large B-cell lymphoma patients with gastrointestinal involvement at diagnosis (2026 · Annals of Hematology · 被引 1)
• Inhibition of Galectin-3 Expression Could Preserve the Immunoregulatory Function of Mesenchymal Stem Cells During Cell Passaging (2025 · Frontiers in Bioscience-Landmark · 被引 1)
• Efficacy and safety of a modified DVD regimen followed by lenalidomide for the treatment of Newly Diagnosed Multiple Myeloma (2025 · Clinics · 被引 1)
• [Clinical Value of a Novel Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma]. (2025 · PubMed)